Product catalog

Research Products & Compound Education

Explore Primo Labs product availability and beginner-friendly research education in one place. This catalog is informational only and does not provide dosing schedules, medical protocols, or treatment advice.

Available Catalog

Product options

Listed sizes are catalog identifiers for research education and inventory presentation. They are not dosing recommendations.

Primo Labs Retatrutide 10mg, 20mg, and 30mg vials

Retatrutide

Triple hormone receptor agonist research category focused on GLP-1, GIP, and glucagon receptor pathways.

10mg 20mg 30mg
View research overview
Primo Labs MOTS-C 40mg vial

MOTS-c

Mitochondrial-derived peptide research category associated with metabolism, insulin sensitivity, and exercise pathways.

40mg
View research overview
Primo Labs GLOW 70mg vial with GHK-Cu, BPC-157, and TB-500 label

GLOW 70mg

Precision-formulated 70mg research peptide blend composed of GHK-Cu, BPC-157, and TB-500.

70mg
View product info

Retatrutide Research Overview

Retatrutide is an investigational triple receptor agonist currently being explored in metabolic and obesity-focused research environments. The compound is designed to interact with GLP-1, GIP, and glucagon receptor pathways, generating significant interest within the scientific community for its potential role in appetite regulation, energy expenditure, and metabolic adaptation models.

Primary Research Areas

  • Obesity and weight-management research
  • Metabolic-health and insulin-response pathways
  • Appetite signaling and satiety regulation
  • Body composition and energy-balance studies
  • Cardiometabolic risk-factor analysis
  • Glucose metabolism and nutrient-partitioning research

MOTS-c Research Overview

MOTS-c is a mitochondrial-derived peptide currently being investigated for its potential involvement in cellular metabolism, insulin signaling, exercise adaptation, and inflammatory-response pathways. Interest in MOTS-c has expanded within longevity and performance-research communities, though human data remains limited.

Primary Research Areas

  • Mitochondrial function and cellular-energy research
  • Metabolic efficiency and glucose-utilization studies
  • Insulin sensitivity and metabolic signaling pathways
  • Exercise performance and endurance adaptation research
  • Longevity, oxidative stress, and inflammation analysis

GLOW 70mg Research Blend Overview

GLOW 70mg commonly refers to a precision-formulated peptide research blend containing a total of 70mg of combined active ingredients. The blend is typically composed of three widely discussed research peptides: GHK-Cu, BPC-157, and TB-500. Within research and wellness communities, the formulation is frequently associated with regenerative, recovery, and skin-quality research models.

Peptide Composition

  • GHK-Cu - 50mg: A copper-binding peptide researched for collagen synthesis, skin elasticity, tissue remodeling, and cellular-repair signaling pathways.
  • BPC-157 - 10mg: A body protection compound studied in tissue-regeneration, inflammation-modulation, and muscle or tendon recovery models.
  • TB-500 - 10mg: A synthetic thymosin beta-4 peptide investigated for cellular migration, angiogenesis, tissue repair, and soft-tissue recovery research.

Common Research Themes

  • Skin rejuvenation and dermal-quality research
  • Collagen, elastin, and hydration pathway analysis
  • Exercise recovery and tissue-regeneration models
  • Inflammation and oxidative-stress research
  • Cellular resilience and recovery signaling
  • Recovery support following cosmetic or recovery-focused procedures

Catalog disclaimer

Primo Labs does not provide medical advice, diagnosis, or treatment. All information is educational only. Catalog sizes are not dosing recommendations. Catalog items are research chemicals and are not intended for human consumption.

Contact

Get in Touch

For product availability, educational questions, or general inquiries, fill out the form below and we'll get back to you.